Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05886751 · ClinicalTrials.gov registry record · NA
Randomized Trial of Trust in Online Videos About Prostate Cancer
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 3,649
- Enrollment target
NCT05886751: Completed NA study, sponsored by NYU Langone Health.
NCT05886751 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 3,649 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (160% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05886751, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,649 participants
- Enrollment target
Study Summary
The study team will evaluate the impact of video characteristics on health consumers' trust in online videos. Participants will be randomized to watch a video by one of four speakers about prostate cancer screening or clinical trials and complete a questionnaire (approximately 15 minutes total).
Primary Outcome
Trust will be reported as a score on a Likert scale and asked as the following question: How much do you trust the information in the video? The total range of score is 1-4, where (1) trust the information completely, (2) trust most of the information, (3) trust some of the information, (4) do not trust the information
Interventions
- OTHER Black Doctor Screening Video
- OTHER White Doctor Screening Video
- OTHER Black Patient Screening Video
- OTHER White Patient Screening Video
- OTHER Black Doctor Clinical Trials Video
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,649 participants |
| Start Date | 2021-08-18 |
| Est. Completion | 2022-01-07 |
| Phase | NA |
What the finished NCT05886751 record still lists
NCT05886751 is an interventional study that assigns participants to a tested intervention. Its 3,649 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (160% higher).
The record links to 0 conditions, and to 5 interventions - of which Black Doctor Screening Video is the first listed.
NCT05886751 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05886751 about?
NCT05886751 is a clinical study titled "Randomized Trial of Trust in Online Videos About Prostate Cancer". The study team will evaluate the impact of video characteristics on health consumers' trust in online videos. Participants will be randomized to watch a video by one of four speakers about prostate cancer screening or clinical trials and complete a questionnaire (approximately 15 minutes total).
What is the current status of trial NCT05886751?
This trial is currently completed. It is a NA study. The enrollment target is 3,649 participants. The study started on 2021-08-18. Estimated completion is 2022-01-07.
What interventions are being tested in trial NCT05886751?
The interventions under investigation include: Black Doctor Screening Video (OTHER), White Doctor Screening Video (OTHER), Black Patient Screening Video (OTHER), White Patient Screening Video (OTHER), Black Doctor Clinical Trials Video (OTHER).
Who is sponsoring clinical trial NCT05886751?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05886751's enrollment target sits among peer trials
3,649 36th of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06702553 · 3,650 participants · Phase 3
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
- NCT07249398 · 3,650 participants · NA
Influence of Social Media Ads on Food Choice - Master Protocol
- NCT06354920 · 3,624 participants · NA
M-Well Bonding Bundle to Improve Patient-Physician Relationships
- NCT06058377 · 3,680 participants · Phase 3
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI